4.7 Article

Vitamin D with Calcium Reduces Mortality: Patient Level Pooled Analysis of 70,528 Patients from Eight Major Vitamin D Trials

期刊

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 97, 期 8, 页码 2670-2681

出版社

ENDOCRINE SOC
DOI: 10.1210/jc.2011-3328

关键词

-

资金

  1. National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]
  2. National Health and Medical Research Council, Australia
  3. Australian Commonwealth Department of Health and Ageing
  4. Danish Council for Independent Research in Medical Sciences [09-070940]
  5. UK Medical Research Council
  6. Chief Scientist Office of the Scottish Government Health Directorates
  7. Danish Osteoporosis Association
  8. Municipality of the City of Randers, Randers Central Hospital, Aarhus County, Denmark
  9. Pharmacy Association of 1991
  10. Bristol-Myers Squibb
  11. Eli Lilly
  12. Shire
  13. Strakan Pharmaceuticals
  14. Furst Medisinsk Laboratorium
  15. Nycomed
  16. National Institutes of Health
  17. MSD
  18. Roche
  19. Amgen
  20. Novartis
  21. Servier
  22. Chief Scientist Office [HSRU1] Funding Source: researchfish
  23. Medical Research Council [MC_UP_A620_1014, U1475000001, MC_U147585824] Funding Source: researchfish
  24. National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish

向作者/读者索取更多资源

Introduction: Vitamin D may affect multiple health outcomes. If so, an effect on mortality is to be expected. Using pooled data from randomized controlled trials, we performed individual patient data (IPD) and trial level meta-analyses to assess mortality among participants randomized to either vitamin D alone or vitamin D with calcium. Subjects and Methods: Through a systematic literature search, we identified 24 randomized controlled trials reporting data on mortality in which vitamin D was given either alone or with calcium. From a total of 13 trials with more than 1000 participants each, eight trials were included in our IPD analysis. Using a stratified Cox regression model, we calculated risk of death during 3 yr of treatment in an intention-to-treat analysis. Also, we performed a trial level meta-analysis including data from all studies. Results: The IPD analysis yielded data on 70,528 randomized participants (86.8% females) with a median age of 70 (interquartile range, 62-77) yr. Vitamin D with or without calcium reduced mortality by 7% [ hazard ratio, 0.93; 95% confidence interval (CI), 0.88-0.99]. However, vitamin D alone did not affect mortality, but risk of death was reduced if vitamin D was given with calcium (hazard ratio, 0.91; 95% CI, 0.84-0.98). The number needed to treat with vitamin D plus calcium for 3 yr to prevent one death was 151. Trial level meta-analysis (24 trials with 88,097 participants) showed similar results, i.e. mortality was reduced with vitamin D plus calcium (odds ratio, 0.94; 95% CI, 0.88-0.99), but not with vitamin D alone (odds ratio, 0.98; 95% CI, 0.91-1.06). Conclusion: Vitamin D with calcium reduces mortality in the elderly, whereas available data do not support an effect of vitamin D alone. (J Clin Endocrinol Metab 97: 2670-2681, 2012)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据